VERTEX PHARMACEUTICALS INC / MA Equity Securities without Readily Determinable Fair Value, Amount
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Equity Securities without Readily Determinable Fair Value, Amount of $80.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2026-08-04
- 2026-06-30: Equity Securities without Readily Determinable Fair Value, Amount $80.10M.
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Amount $81.50M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount |
|---|---|
| 2026-06-30 | $80.10M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $81.50M 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |